MENU

DXR Stock Daxor (DXR, $12.94) Stochastic Oscillator left the overbought zone on November 18, 2025

A.I.dvisor
at Tickeron.com
Loading...
DXR - Daxor Corp
Stochastic signal
Bearish Trend
Odds of DOWN Trend
Tickeron
Stochastic signal
Price: $12.944
Daily change: $0 (0%)
Daily volume: 4.3K
Capitalization: $64.5M
Industry: Pharmaceuticals: Other

This is a signal that DXR's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position. A.I.dvisor identified 70 similar cases where DXR's stochastic oscillator exited the overbought zone, and of them led to successful outcomes. Odds of Success:

DXR's Indicator enters downward trend

The Aroon Indicator for DXR entered a downward trend on November 05, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 129 similar instances where the Aroon Indicator formed such a pattern. In of the 129 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where DXR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on DXR as a result. In of 123 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

DXR moved above its 50-day moving average on November 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DXR advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

DXR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.846) is normal, around the industry mean (9.109). P/E Ratio (82.456) is within average values for comparable stocks, (160.120). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.560). DXR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (19.881) is also within normal values, averaging (111.039).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
DXR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a provider of original medical equipment for medical personnel

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
109 Meco Lane
Phone
+1 212 330-8500
Employees
12
Web
https://www.daxor.com